Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.

Slides:



Advertisements
Similar presentations
Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):
Advertisements

Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome by Jacob H. Rand,
Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma by Joshua Richter, Natalia Neparidze,
Hairy Cell Leukemia Variant Has Similar Survival to Classical Disease Despite Poorer Responses to Initial Therapy: A 30-Year Experience from Memorial Sloan.
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia by Alessandra Ferrajoli, Michael J. Keating,
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell–, and not B cell–, dependent antilymphoma immunity by Hong Qin, Soung-chul.
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,
Do HSCs divide asymmetrically?
VEGF therapy: risky business for established plaques?
by Masako Moriuchi, Hiroyuki Moriuchi, and Anthony S. Fauci
EBV DNA: a Hodgkin lymphoma biomarker?
by Toru Takahashi, Toshiaki Yujiri, and Yukio Tanizawa
Polyphosphates rock! A role in thrombosis?
Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients by Nina.
Defects in DBA: more than meets the eye
Next-generation leukemia immunotherapy
In utero transplantation may soon be in delivery
Retroviral and Chemical Mutagenesis Identifies Pax5 as a Tumor Suppressor in B-Progenitor Acute Lymphoblastic Leukemia by Jinjun Dang, Charles G Mullighan,
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
T-cell epitopes within the complementarity-determining and framework regions of the tumor-derived immunoglobulin heavy chain in multiple myeloma by Lotta.
by Zhenping Zhu Blood Volume 108(6): September 15, 2006
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants by.
Tax fingerprint in adult T-cell leukemia
How I treat elderly patients with myeloma
Mechanical Properties of Stored Red Blood Cells Using Optical Tweezers
Nonmyeloablative conditioning for relapsed follicular lymphoma
Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)
Autologous Transplantation Therapy for Chronic Myelogenous Leukemia
Fusion genes in cord blood
An Unusual Cause of Abdominal Pain in Sickle Cell Disease
What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):
Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein,
by Lewis Hsu, Bhalchandra Diwan, Jerrold M. Ward, and Constance T
Suppression, surprise: galectin-10 and Treg cells
Taking a leaf from the book of oral tolerance
Has the T cell bitten off more than it can chew?
Blood Volume 92(10): November 15, 1998
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Stage C or not stage C…? by Claire Dearden Blood
by Paul A. Carpenter, Meei-Li Huang, and George B. McDonald
HU for acute treatment of sickle VOC?
by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros
Allogeneic Stem Cell Transplantation in Myelofibrosis
Anergy: the CLL cell limbo
Low Dose Thymoglobulin Results In Improved Outcomes After Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) For Patients With Acute Myeloid.
Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal.
by Santosh L. Saraf, Xu Zhang, Tamir Kanias, James P. Lash, Robert E
Designer Lipids Advance Systemic siRNA Delivery
Erratum The American Journal of Human Genetics
by Fumiko Chino, Arif H. Kamal, Junzo Chino, and Thomas W. LeBlanc
Pauline Damien, David S. Allan 
by Hannah L Bader, Tracy Pritchett, and Tien Hsu
Changes throughout time in the lineage content of clones regenerated in secondary mice. Changes throughout time in the lineage content of clones regenerated.
by H. Ddungu, M. Waiswa, R. Kruisselbrink, P. Kagoma, and M. Crowther
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
Figure 3 Fingolimod inhibits TNF-α secretion by human monocytes Peripheral blood mononuclear cells from healthy donors were briefly exposed to increasing.
Sickle cells and sickle trait in thrombosis
Bigger, Stronger, Faster: Chimeric Antigen Receptor T Cells Are Olympic Killers by Paul J Neeson, Alexander James Davenport, Joseph A Trapani, Michael.
Rituximab immunotherapy: it’s getting personal
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
A binding relationship with thrombin
Pure red cell aplasia by Robert T. Means Blood
A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.
Initial treatment of CLL: integrating biology and functional status
by Victor A. Chow, Mazyar Shadman, and Ajay K. Gopal
Balancing bleeding in brain metastases
Cold agglutinin disease
Presentation transcript:

Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus–associated lipodystrophy syndrome. Blood. 2000;95:3191-3198. Blood Volume 96(5):1673-1673 September 1, 2000 ©2000 by American Society of Hematology

Figure 1B. Figure 1B American Society of Hematology Blood 2000;96:1673 ©2000 by American Society of Hematology

Figure 2C. Figure 2C American Society of Hematology Blood 2000;96:1673 ©2000 by American Society of Hematology

Figure 3B-C. Figure 3B-C American Society of Hematology Blood 2000;96:1673 ©2000 by American Society of Hematology